Astral Systems Raises £23 Million to Advance Fusion Technology Development

Bristol-based deep-tech company Astral Systems has successfully completed a Series A funding round, securing £23 million. This investment will be used to accelerate the development of its innovative fusion technology. The funding supports the production of medical isotopes for cancer treatment, expansion of its modular reactor program, and broader fusion research efforts.